{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T14:54:07Z","timestamp":1761058447979},"reference-count":27,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2006,4,27]],"date-time":"2006-04-27T00:00:00Z","timestamp":1146096000000},"content-version":"vor","delay-in-days":5656,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Experimental Allergy"],"published-print":{"date-parts":[[1990,11]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>We evaluated the effect of pre\u2010treatment with 1 and 2 mg b.i.d. of ketotifen on the early response to nasal challenge in a double\u2010blind cross\u2010over trial. Weekly nasal challenges were performed in 10 allergic subjects after 1 hr and 1, 2, 3 and 4 weeks of ketotifen administration. The response to nasal challenge was monitored by counting the number of sneezes, the assessment of subjective symptoms, and by measuring the levels of histamine and TAME\u2010esterase activity in recovered nasal lavages. The number of sneezes diminished significantly after a single dose of drug with both the 1 and 2 mg doses. Prolonged pre\u2010treatment did not improve the results. The levels of histamine and TAME\u2010esterase activity in recovered nasal lavages were not changed significantly by either pre\u2010treatment at either dose. Although the number of subjects was small, our data suggest that ketotifen diminishes allergic symptomatology by its antihistaminic properties rather than by inhibiting histamine release from mast cells. As we did not look into the effects of ketotifen on other products generated by mast cells (prostanoids, leukotrienes and tryptase), we cannot fully rule out an effect on mast cells.<\/jats:p>","DOI":"10.1111\/j.1365-2222.1990.tb02711.x","type":"journal-article","created":{"date-parts":[[2006,4,28]],"date-time":"2006-04-28T13:24:23Z","timestamp":1146230663000},"page":"701-705","source":"Crossref","is-referenced-by-count":14,"title":["Ketotifen reduces sneezing but not histamine release following nasal challenge with antigen"],"prefix":"10.1111","volume":"20","author":[{"given":"A. M.","family":"MAJCHEL","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"PROUD","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"ANNE","family":"KAGEY\u2010SOBOTKA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L. M.","family":"LICHTENSTEIN","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R. M.","family":"NACLERIO","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2006,4,27]]},"reference":[{"key":"e_1_2_1_2_2","doi-asserted-by":"publisher","DOI":"10.1002\/bms.1200100307"},{"key":"e_1_2_1_3_2","first-page":"723","volume-title":"Allergy: principles and practice","author":"Trzeciakowski JP","year":"1988"},{"key":"e_1_2_1_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/0091-6749(89)90317-5"},{"key":"e_1_2_1_5_2","first-page":"141","article-title":"Antianaphylactic properties of ketotifcn in animal experiments","volume":"17","author":"Martin M","year":"1978","journal-title":"Triangle"},{"key":"e_1_2_1_6_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02111438"},{"key":"e_1_2_1_7_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00505315"},{"key":"e_1_2_1_8_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-104-4-507"},{"key":"e_1_2_1_9_2","first-page":"313","article-title":"Inhibition of chemical mediator release from human leukocytes by a new antiasthma drug HC 20\u2013511 (ketotifen)","volume":"14","author":"Tomioka H.","year":"1979","journal-title":"Monogr Allergy"},{"key":"e_1_2_1_10_2","first-page":"335","article-title":"Effects of ketotifen upon responses to platelet activating factor: a basis for asthma prophylaxis","volume":"56","author":"Morley J","year":"1986","journal-title":"Ann Allergy"},{"key":"e_1_2_1_11_2","first-page":"437","volume-title":"Allergy: principles and practice","author":"Naclerio RM","year":"1988"},{"key":"e_1_2_1_12_2","first-page":"213","volume-title":"Rhinitis and asthma\u2013 similarities and differences","author":"Naclerio RM","year":"1990"},{"key":"e_1_2_1_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/0091-6749(88)90035-8"},{"key":"e_1_2_1_14_2","first-page":"597","article-title":"Mediator release after nasal airway challenge with allergen","volume":"128","author":"Naclerio RM","year":"1983","journal-title":"Am Rev Rcspir Dis"},{"key":"e_1_2_1_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/0003-2697(74)90093-1"},{"key":"e_1_2_1_16_2","first-page":"9977","article-title":"Plasma kallikrein during experimentally\u2010induced allergic rhinitis:role m kinin formation and contribution to TAME\u2010esterase activity in nasal secretions","volume":"137","author":"Baumgartcn CR.","year":"1986","journal-title":"J Immunol"},{"key":"e_1_2_1_17_2","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.4049\/jimmunol.137.4.1323","article-title":"Concentrations of glandulnr kallikrein in human nasal secretions during experimentally\u2010induced allergic rhinitis","volume":"137","author":"Baumgarten CR","year":"1986","journal-title":"J Immunol"},{"key":"e_1_2_1_18_2","doi-asserted-by":"publisher","DOI":"10.1002\/aja.1001240205"},{"key":"e_1_2_1_19_2","first-page":"605","volume-title":"The pharmacologic basis of therapeutics","author":"Douglas WW.","year":"1987"},{"key":"e_1_2_1_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/0091-6749(85)90805-X"},{"key":"e_1_2_1_21_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00458318"},{"key":"e_1_2_1_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/0091-6749(89)90410-7"},{"key":"e_1_2_1_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/0091-6749(89)90362-X"},{"key":"e_1_2_1_24_2","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm\/142.1.167"},{"key":"e_1_2_1_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/0091-6749(88)90094-2"},{"key":"e_1_2_1_26_2","doi-asserted-by":"publisher","DOI":"10.1288\/00005537-198906000-00006"},{"key":"e_1_2_1_27_2","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1001\/jama.1986.03370020071030","article-title":"Demonstration of inhibition of mediator release from human mast cells by azatadine base","volume":"255","author":"Togias AG","year":"1986","journal-title":"J Am Med Assoc"},{"key":"e_1_2_1_28_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198507113130201"}],"container-title":["Clinical &amp; Experimental Allergy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2222.1990.tb02711.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2222.1990.tb02711.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,27]],"date-time":"2023-09-27T07:55:46Z","timestamp":1695801346000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2222.1990.tb02711.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1990,11]]},"references-count":27,"journal-issue":{"issue":"6","published-print":{"date-parts":[[1990,11]]}},"alternative-id":["10.1111\/j.1365-2222.1990.tb02711.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2222.1990.tb02711.x","archive":["Portico"],"relation":{},"ISSN":["0954-7894","1365-2222"],"issn-type":[{"value":"0954-7894","type":"print"},{"value":"1365-2222","type":"electronic"}],"subject":[],"published":{"date-parts":[[1990,11]]}}}